Enhanced Geothermal System Market Players:
- AltaRock Energy, Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Fuji Electric Co., Ltd
- Calpine
- Bestec GmbH
- MITSUBISHI HEAVY INDUSTRIES, LTD
- Enel SpA
- Toshiba Corporation
- Ansaldo Energia
- Energy Development Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of enhanced geothermal system is estimated at USD 2.45 billion.
The global enhanced geothermal system market size was over USD 2.34 billion in 2025 and is anticipated to witness a CAGR of around 5.4%, crossing USD 3.96 billion revenue by 2035.
North America enhanced geothermal system market is projected to account for 36% revenue share by 2035, driven by the increasing number of enhanced geothermal projects supported by long-term capacity expansion targets.
Key players in the market include Novartis AG, Sun Pharmaceutical Industries Ltd, Midatech Pharma PLC, Ipsen Pharma, Chiasma Inc., Peptron, Inc., CRINETICS PHARMACEUTICALS, Dauntless Pharmaceuticals, Camurus AB, Teva Pharmaceuticals Inc, and Pfizer Inc.
